Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBG
Primary Purpose
Diabetes
Status
Terminated
Phase
Not Applicable
Locations
Japan
Study Type
Interventional
Intervention
;Accu-Chek Compact Plus LCM bulk Japan
Sponsored by

About this trial
This is an interventional diagnostic trial for Diabetes
Eligibility Criteria
Inclusion Criteria:
1. Age:= and >20 years. 2. Intend to paticipate in this study after education of structured testing. 3.HbA1c:= and >7.5% in the recect 2 months.
Exclusion Criteria:
1.Pregancy. 2. Heavy complication 3. judged unsuitable by doctor
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Single arm
Arm Description
Outcomes
Primary Outcome Measures
Improvement in HbA1c in 6 months
Secondary Outcome Measures
1. Comparison with historical control in HbA1c change.
2. Change in blood gulucose.
3. Change in BMI.
4. Occurance of sever hypoglycemia.
5. Doctor's opinion for Accu-Chek 360° View.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01820169
Brief Title
Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBG
Official Title
Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBG
Study Type
Interventional
2. Study Status
Record Verification Date
September 2016
Overall Recruitment Status
Terminated
Why Stopped
Only 2 patients screened but none of them were enrolled.
Study Start Date
April 2013 (undefined)
Primary Completion Date
December 2013 (Actual)
Study Completion Date
December 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hoffmann-La Roche
4. Oversight
5. Study Description
Brief Summary
This clinical study is to determine if the use of structured testing, which is a blood glucose monitoring, via the Accu-Chek 360° View blood glucose analysis tool has a positive effect on the subjects overall glycemic control.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
2 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Single arm
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
;Accu-Chek Compact Plus LCM bulk Japan
Intervention Description
HbA1c would be changed by more careful control in blood glucose with SMBG.
Primary Outcome Measure Information:
Title
Improvement in HbA1c in 6 months
Time Frame
6 months
Secondary Outcome Measure Information:
Title
1. Comparison with historical control in HbA1c change.
Time Frame
Baseline to 6 months
Title
2. Change in blood gulucose.
Time Frame
Baseline to 6 months
Title
3. Change in BMI.
Time Frame
Baseline to 6 months
Title
4. Occurance of sever hypoglycemia.
Time Frame
Baseline to 6 months
Title
5. Doctor's opinion for Accu-Chek 360° View.
Time Frame
Baseline to 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Eligibility Criteria
Inclusion Criteria:
1. Age:= and >20 years. 2. Intend to paticipate in this study after education of structured testing. 3.HbA1c:= and >7.5% in the recect 2 months.
Exclusion Criteria:
1.Pregancy. 2. Heavy complication 3. judged unsuitable by doctor
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Naoki Sakane
Organizational Affiliation
National organization Hospital Kyoto Medical Center
Official's Role
Principal Investigator
Facility Information:
City
Kyoto
ZIP/Postal Code
612-8555
Country
Japan
12. IPD Sharing Statement
Learn more about this trial
Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBG
We'll reach out to this number within 24 hrs